Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) related to its sale to Indivior Pharmaceuticals, Inc. Under the terms of the proposed transaction, Supernus shareholders are expected to receive 1.5401 common shares of Indivior for each share of Supernus.

Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) related to its merger with Supernus Pharmaceuticals, Inc. Upon closing of the proposed transaction, Indivior shareholders will own approximately 56.5% of the combined company.

Atkore Inc.

Atkore Inc. (NYSE: ATKR) related to its sale to Prysmian S.p.A. Under the terms of the proposed transaction, Atkore shareholders are expected to receive $95.00 per share in cash.

Planet 13 Holdings Inc.

Planet 13 Holdings Inc. (OTCQX: PLNH) related to its merger with Vireo Growth Inc. Under the terms of the proposed transaction, Planet 13 shareholders are expected to receive 0.015383618 shares of Vireo for each Planet 13 share.

MarketAxess Holdings Inc.

MarketAxess Holdings Inc. (NASDAQ: MKTX) related to its sale to Intercontinental Exchange, Inc. Under the terms of the proposed transaction, MarketAxess shareholders are expected to receive $167.00 per share in cash.

Sanara MedTech Inc.

Sanara MedTech Inc. (NASDAQ: SMTI) related to its sale to MiMedx Group, Inc. Under the terms of the proposed transaction, Sanara shareholders are expected to receive $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara common stock.

CBIZ, Inc.

CBIZ, Inc. (NYSE: CBZ) related to its sale to Grant Thornton Advisors LLC. Under the terms of the proposed transaction, CBIZ shareholders are expected to receive $55.00 per share in cash.

Luxfer Holdings PLC

Luxfer Holdings PLC (NYSE: LXFR) related to its sale to affiliates of Wynnchurch Capital L.P. Under the terms of the proposed transaction, Luxfer shareholders are expected to receive $17.37 per share in cash.

Forte Biosciences, Inc.

Forte Biosciences, Inc. (NASDAQ: FBRX) related to its sale to argenx BV. Under the terms of the proposed transaction, Forte Biosciences shareholders are expected to receive $77.00 per share in cash.

Safety Insurance Group Inc.

Safety Insurance Group Inc. (NASDAQ: SAFT) related to its sale to an affiliate of Mapfre S.A. Under the terms of the proposed transaction, Safety Insurance stockholders are expected to receive $105.00 per share in cash.